| Title | Date | PubMed ID |
|---|
| Uncharged nucleoside inhibitors of β-1,4-galactosyltransferase with activity in cells. | 2016 Mar 11 | 26882174 |
| Probing the acceptor active site organization of the human recombinant β1,4-galactosyltransferase 7 and design of xyloside-based inhibitors. | 2015 Mar 20 | 25568325 |
| Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells. | 2015 Jan 10 | 25462875 |
| Expression of natural human β1,4-GalT1 variants and of non-mammalian homologues in plants leads to differences in galactosylation of N-glycans. | 2014 Oct | 25082356 |
| Crystal structures of β-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding. | 2013 Nov 1 | 24052259 |
| β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. | 2013 Oct | 23882130 |
| Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma. | 2013 May 10 | 23583406 |
| Estrogen induced β-1,4-galactosyltransferase 1 expression regulates proliferation of human breast cancer MCF-7 cells. | 2012 Oct 5 | 22982306 |
| Osteopontin increases the expression of β1, 4-galactosyltransferase-I and promotes adhesion in human RL95-2 cells. | 2012 Aug | 22847114 |
| The functional interaction between CDK11p58 and β-1,4-galactosyltransferase I involved in astrocyte activation caused by lipopolysaccharide. | 2012 Aug | 22527143 |